Laura Zamora

856 total citations
19 papers, 669 citations indexed

About

Laura Zamora is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Laura Zamora has authored 19 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Laura Zamora's work include HIV/AIDS drug development and treatment (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and HIV Research and Treatment (7 papers). Laura Zamora is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and HIV Research and Treatment (7 papers). Laura Zamora collaborates with scholars based in Spain, Argentina and United States. Laura Zamora's co-authors include Bonaventura Clotet, Mayte Pérez‐Olmeda, M Gómez-Cano, Teresa Puig, Vincent Soriano, Amalia Rubio, Lı́dia Ruiz, Manuel Leal, Juan A. Pineda and E Soriano and has published in prestigious journals such as PLoS ONE, AIDS and Vaccine.

In The Last Decade

Laura Zamora

18 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Zamora Spain 9 410 310 233 122 100 19 669
Christopher J. Lahart United States 10 343 0.8× 275 0.9× 224 1.0× 50 0.4× 34 0.3× 13 627
Janie Eddy United States 10 748 1.8× 643 2.1× 339 1.5× 105 0.9× 21 0.2× 11 1.1k
Nanci Hawley‐Foss Canada 10 298 0.7× 341 1.1× 160 0.7× 167 1.4× 11 0.1× 19 588
G. Friedland United States 11 315 0.8× 169 0.5× 323 1.4× 30 0.2× 22 0.2× 14 534
A. J. Saah United States 7 195 0.5× 182 0.6× 175 0.8× 30 0.2× 8 0.1× 10 488
Rafael de la Rosa Spain 15 186 0.5× 207 0.7× 215 0.9× 113 0.9× 12 0.1× 22 541
Valerio Tozzi Italy 10 261 0.6× 296 1.0× 84 0.4× 18 0.1× 23 0.2× 21 395
Elisabeth H. Gisolf Netherlands 10 328 0.8× 235 0.8× 112 0.5× 18 0.1× 28 0.3× 17 425
Andreas Lind Norway 11 205 0.5× 83 0.3× 70 0.3× 81 0.7× 13 0.1× 32 383
Rebekah Puls Australia 16 421 1.0× 425 1.4× 109 0.5× 88 0.7× 9 0.1× 26 639

Countries citing papers authored by Laura Zamora

Since Specialization
Citations

This map shows the geographic impact of Laura Zamora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Zamora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Zamora more than expected).

Fields of papers citing papers by Laura Zamora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Zamora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Zamora. The network helps show where Laura Zamora may publish in the future.

Co-authorship network of co-authors of Laura Zamora

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Zamora. A scholar is included among the top collaborators of Laura Zamora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Zamora. Laura Zamora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ambrosioni, Juan, Omar Sued, David Nicolás, et al.. (2015). Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012). PLoS ONE. 10(6). e0125837–e0125837. 21 indexed citations
2.
3.
Blasco, Antonio Javier, Josep M. Llibre, José Ramón Arribas, et al.. (2013). Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2013 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica. 31(9). 568–578. 10 indexed citations
4.
Blasco, Antonio Javier, José Ramón Arribas, Vicente Boix, et al.. (2012). Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH). Enfermedades Infecciosas y Microbiología Clínica. 30(6). 283–293. 8 indexed citations
5.
Gil‐Sanz, Cristina, Felipe García, José M. Miró, et al.. (2011). Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue. Journal of Virological Methods. 174(1-2). 69–76. 3 indexed citations
6.
Gil‐Sanz, Cristina, Núria Climent, Felipe García, et al.. (2011). Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines. Vaccine. 29(34). 5711–5724. 8 indexed citations
7.
León, Agathe, Cesar A. Cáceres, Maite de Blas, et al.. (2011). A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study. PLoS ONE. 6(1). e14515–e14515. 66 indexed citations
8.
Blasco, Antonio Javier, José Ramón Arribas, Bonaventura Clotet, et al.. (2011). Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial. Enfermedades Infecciosas y Microbiología Clínica. 29(10). 721–730. 7 indexed citations
9.
Miró, José M., Christian Manzardo, Laura Zamora, et al.. (2011). Manejo clínico de la infección aguda y crónica por el virus de la inmunodeficiencia humana antes del inicio del tratamiento antirretroviral. Enfermedades Infecciosas y Microbiología Clínica. 29(10). 759–772.
10.
Zamora, Laura & José María Gatell. (2008). Atazanavir en el tratamiento de simplificación. Enfermedades Infecciosas y Microbiología Clínica. 26. 14–21. 4 indexed citations
11.
Puig, Teresa, Mayte Pérez‐Olmeda, Amalia Rubio, et al.. (2000). Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. AIDS. 14(6). 727–732. 55 indexed citations
12.
Zamora, Laura, et al.. (2000). Determination of stavudine in human plasma and urine by high-performance liquid chromatography using a reduced sample volume. Journal of Chromatography B Biomedical Sciences and Applications. 746(2). 183–189. 20 indexed citations
13.
Rubio, Amalia, M Gómez-Cano, Teresa Puig, et al.. (1999). Presence of Genotypic Resistance in Nucleoside Analogue-Treated HIV-1-Infected Patients with Undetectable Viral Load. Antiviral Therapy. 4(1). 45–49. 16 indexed citations
14.
Gómez-Cano, M, Amalia Rubio, Teresa Puig, et al.. (1998). Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS. 12(9). 1015–1020. 263 indexed citations
15.
Guelar, Ana, Julian González-Martín, José M. Gatell, et al.. (1995). Patterns of resistance of Mycobacterium tuberculosis in Spanish patients infected with human immunodeficiency virus type 1 (HIV-1). Clinical Microbiology and Infection. 1(2). 110–113. 2 indexed citations
16.
Mallolas, Josep, Laura Zamora, Josep M. Gatell, et al.. (1993). Primary prophylaxis for Pneumocystis carinii pneumonia. AIDS. 7(1). 59–64. 37 indexed citations
17.
Guelar, Ana, José M. Gatell, Luisa Seco Lozano, et al.. (1993). A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS. 7(10). 1345–1350. 142 indexed citations
18.
Zamora, Laura, et al.. (1990). Fisioterapia del deporte. Dialnet (Universidad de la Rioja). 1 indexed citations
19.
Zamora, Laura, et al.. (1990). Fisioterapia de la mano. Dialnet (Universidad de la Rioja). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Lahart Breakdown of academic impact, for papers by Janie Eddy Breakdown of academic impact, for papers by Nanci Hawley‐Foss Breakdown of academic impact, for papers by G. Friedland Breakdown of academic impact, for papers by A. J. Saah Breakdown of academic impact, for papers by Rafael de la Rosa Breakdown of academic impact, for papers by Valerio Tozzi Breakdown of academic impact, for papers by Elisabeth H. Gisolf Breakdown of academic impact, for papers by Andreas Lind Breakdown of academic impact, for papers by Rebekah Puls
Rankless by CCL
2026